Smallcaps
RVNL Weekly Flag BreakoutA flag and pole breakout has been observed in the weekly chart of NSE:RVNL . One can create a fresh position in the scrip around 135 or below with a stopploss of rs 115 for targets of 155/175/195
Exit the position if the stop loss is triggered on WCB.
DO YOU WANT ALL MY RESEARCH FOR FREE THEN DON'T FORGET TO FOLLOW ME.
I AM EAGERLY WAITING FOR YOUR COMMENTS ON THE STUDY...
Disclaimer: Content shared is for information and education purposes only and should not be treated as investment or trading advice. Please do your own analysis or take independent professional financial advice before making any investments based on your own personal circumstances. Investment in securities are subject to market risks, please carry out your due diligence before investing. And last but not the least, past performance is not indicative of future returns.
Balmer Lawrie: Flag BO on Weekly TFHi,
A Bullish flag and Pole pattern is emerging on the weekly chart of NSE:BALMLAWRIE Volume and price breakout both are confrimed.
All the details are mentioned on the charts.
Exit the position if the stop loss is triggered on WCB.
DO YOU WANT ALL MY RESEARCH FOR FREE THEN DON'T FORGET TO FOLLOW ME.
I AM EAGERLY WAITING FOR YOUR COMMENTS ON THE STUDY...
Disclaimer: Content shared is for information and education purposes only and should not be treated as investment or trading advice. Please do your own analysis or take independent professional financial advice before making any investments based on your own personal circumstances. Investment in securities are subject to market risks, please carry out your due diligence before investing. And last but not the least, past performance is not indicative of future returns.
AVG logistic above all resistance and daily turn bullishdrawn month week and daily support line
month & week already in bullish then a daily candle turns bullish
may go long.
this strategy originally derived from prof Manish Taneja of IFMC institute(google)
target may vary but SL great in this strategy.
in target level price must get resistance as it's a darvas box forming, but if a long candle with huge volume break this Darvas box then upside mom. may occur
150 % in just 1 MonthAnalyzing chart on longer time frame will give us a Stocks with Multifold Return .
Points to consider to find such stocks :-
Multi Year Support
Buying from Support Levels (Big Green Volume Candles)
RSI Start to move up (Bullish Momentum)
Delivery Based Buying (High Delivery Quantity)
Not a BUY Recommendation at these levels (SL will be very High now)
Somi Conveyor: Cup and Handle BreakoutCup and handle formation which started in Feb 2018. Looks like it ends as the Chart breakouts from it's horizontal Trendline above the cup & handle's base line. Brace for super long targets with strict stoploss in any case the momentum gets slow given the chart is based on a weekly timeframe.
Clear Flag and pole pattern in Ramco Cement.Ramco Cement is forming a flag and pole pattern on the weekly charts and there is a bullish moving averages cross over.
Stock has been consolidating for a month and is trading in a 40 points range. The break out can give good 150+ points as per the measure target.
Indian markets are trading near the ATH and stock will follow the indices.
On the daily time frame, the stock is respecting the 20 EMA and is taking good support from it. RSI indicator is showing some negative divergence and is around 50 levels.
Entry :- Above 950
Target :- 1037, 1090
Swing and positional trades can be initiated in the stock. Even short term stock purchase can also be created in the stock.
Wait for the market to show some break out as there is a bullish pattern formation.
Early move prediction in a small cap company (Eclerx Services).Eclerx services after a consolidation of 12 months has given a break out and is showing a trend reversal signal. The stock after the break out has given a 10%+ up move and in this month formed a gravestone doji from the resistance zone forming double top pattern.
Currently, the stock is trading around 1625 levels, testing the 38.2% fib levels and the support zone around 1550 levels coinside with 50% fib levels.
The volume incidator is also showing some positive sentiment. Up move are in high volumes and the bearish days are showing low volumes.
The stock is holding on the higher levels and has consolidated for 4 weeks forming a flag and pole pattern.
A retest and another bull leg is how the market move.
If the stock come to test the 50% levels, it can be bought and accumulated even on the lower levels of 1456 (200 DMA).
Entry levels :- 1550, 1456
Targets :- 1750-1800, 1950
Time frame :- 3-4 months.
Market are trading at ATH. The stocks will follow the market.
This is a small cap company and looks fundamental good. The stock can be considered for long term investing too.
Wait for price action near the levels before making position in the stock.
swinng trade ;long term investment; min 70% return; short term
midcap stocks are going to boom.
long term investment; min 70% return
huge potential is there.
investment ;
inverted head and shooulder is there
if you are intrested in investmet, go for it with small risk,
more possibility is there for breakout.
intraday, swing, short term; min 70% returns, fundamentally goodAdd this to your watchlist wait for conformation
fundamentally good stock
.
.
.
.
Once it reaches : 1100
then it come for retracement upto: 990
after retracement it again comes to : 1050
that is what entry point is,.
'
;
'
'
stay for update
Persistent Weekly brack-out and pull backThe presistance system is the IT sector good stock to buy the current level the weekly chart is clear show that dec 2021 the 5018 is resistance level. but currenlty the share is brackout and now the price is pullback.
If you are buy this level, this is the low risk & high return expected.
Note:- This is only for education purpose// for more subscribe my youtube channel
MEDANTA- NEXT DREAM RUN IPO !1.After listing rally stock formed good base with volume contraction ( first mature base)
2.Now stock trading in range from last breakout high ( forming second mature base)
3.Now closing above 530 with good volume will trigger next upmove
4. Stop loss - closing below upword slanting trendline
5. Target - 574/610/680+
INDHOTEL- 5th Wave Candidate heading for 360+++Attached: INDHOTEL Daily Live Market Chart as of 26th April 2023
An Ending Diagonal in Wave 4 marked as ABCDE and then Price has been moving Up since then, close to its All Time High
Look at Peer Hotel Stocks, they are also making New 52 Week Highs and Breaking Out so Indian Hotels too should follow the Hotel Sector in its journey up
Upside Target:
north of 360
and then take Reverse Fib Level of 4th Wave:
1.272
1.382
1.5
1.618
GSFC Lamba Race Ka GhodaGSFC the moves are impulsive we have first 9 Waves up it could further subdivide in 13 waves will have to wait but any pullback to 155-147 will be good add zone for long term investment.
I am not a SEBI Registered Analyst please consult your advisor before investing charts shared for education purpose only.
PRICOL - DAILY RANGE BREAKOUT New 52 Week and All time High
Rs.230.95 hit today
Performance Today
Outperformed Sector by 2.3%
Day's High
Stock touched an intraday high of Rs 230.95
(3.59%)
~ Moving Averages
Pricol Ltd is trading higher than 5 day, 20 day, 50 day, 100 day and 200 day moving averages
Rising Investor Participation
Delivery Vol of 7.74 lacs on 31 Mar has risen by 69.65% against 5-day avg delivery vol
4 Liquidity
Based on 2% of 5 day average traded Value the stock is liquid enough for trade size of Rs 0.71
Cr
Fundamental
Net Sales (HY)
At Rs 989.92 cr has Grown at 21.54 %
Roce (HY)
Highest at 18.85 %
Debt-Equity Ratio (HY)
Lowest at 0.12 times
Pat (Q)
At Rs 26.76 cr has Grown at 54.2 %
Pbt Less Oi (Q)
At Rs 26.54 cr has Grown at 23.04 %
Best entry price around 220 and 200
Hemostemix Inc. is on a mission to flourish the health sector .(TSX: HEM) There are several top stem cell companies that are engaged in various activities related to stem cell research, development, and commercialization. The top companies are engaged in the development of regenerative medicine products based on mesenchymal lineage adult stem cells. The top stem cell companies are engaged in various activities related to stem cell research, development, and commercialization, with the ultimate goal of developing new treatments and therapies for a range of diseases and conditions.
In the global stem cell market, Hemostemix Inc. has a role as a key player in the development of regenerative medicine therapies. The company's innovative approach to using a patient's own cells to promote healing has the potential to address a wide range of chronic diseases and conditions. Hemostemix, Inc. has been involved in several clinical trials to evaluate the safety and efficacy of its ACP-01 therapy in patients with conditions such as critical limb ischemia, peripheral artery disease, and osteoarthritis. The company has also been granted patents for its technology in several countries. Hemostemix Inc. is a Canadian biotechnology company that specializes in the development of innovative stem cell therapies. The company's lead product is ACP-01, which is a proprietary cell therapy that uses a patient's own blood cells to stimulate the body's natural healing process.
Hemostemix continues to flourish in the healthcare sector.Hemostemix Inc. (TSXV: HEM) has emerged as a pioneer biotechnology company in the healthcare sector. This company is continuously thriving to shape and develop blood-derived stem cell therapies for medical conditions. With its innovative approach and proficient technology, the company constantly tries to improve the lives of patients with cardiovascular diseases, autoimmune diseases, and other medical conditions. Hemostemix Inc. tries to revolutionize the field of regenerative medicine by offering hope to millions of people around the world. This company has effective proprietary platform technology. This proprietary platform technology is based on 10 years of clinical data, which demonstrates the ability of our autologous cell product for regeneration of damaged and diseased tissue.
Recently, the company Hemostemix Inc. announced that it was re-pricing its 14 million common share units to $0.20 each. Basically, each unit consists of one common share in the capital of the company (referred to as the "common share") and one common share purchase warrant (referred to as the "warrant"). Subject to the accelerated expiry provision detailed below, each full warrant entitles the holder to purchase one common share for $0.65 per common share for a period of 24 months following the closing of the offering.
According to the prospectus exemption underlined in Alberta Securities Commission Rule 45-513, "Prospectus Exemption for Distribution to Existing Security Holders," and in comparable documents in other Canadian provinces and territories, the offering is made available mostly to current shareholders of the company who, as of the close of business on January 2, 2023, hold common shares of the company. The existing shareholder exemption restricts a shareholder to a maximum investment of $15,000 over the course of a year unless the shareholder has sought advice about the investment's suitability, and, if the shareholder resides in a Canadian jurisdiction, that advice has been sought from a person who is registered as an investment dealer in that jurisdiction. The company intends to prorate the subscriptions received in the event that subscriptions received from investors who depend on the current shareholder exemption exceed the financing's maximum amount. Additionally, the company made the offering available to a select group of subscribers in accordance with the investment dealer exemption. The company verifies that there are no relevant facts or major changes regarding the company that have not been generally reported in compliance with the requirements of the investment dealer exemption.